Total Funding
38
42
Total FundingSeries A raised
Growth Score 38 in past quarter
-1 pts
Heat Score 42 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
42836
Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.
- Joseph Ingoglia: Chief Commercial Officer
Frank Nicholas Franano: Co-Founder, President, and CEOPast Role: Flow Forward Medical, Founder and CEO
About the Company
Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. The company's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. These products enable
physicians to perform better, faster, and safer vascular occlusion procedures.
The company was founded in 2011 and is based in Olathe, Kansas.